文献速递消化道肿瘤与早癌消化内镜

右半结肠大型(≥20 mm)无蒂息肉中内镜下可治愈的低风险癌的患病率

Prevalence of Endoscopically Curable Low-Risk Cancer Among Large (≥20 mm) Nonpedunculated Polyps in the Right Colon.
PubMed 文献 · Clin Gastroenterol Hepatol · 2024-07-31

该前瞻性多中心队列分析了180个月内转诊行内镜下切除的2956例患者共3294枚右半结肠散发型大型无蒂息肉。右半结肠大型无蒂息肉中癌症总患病率为4.4%(131/2956),低风险癌仅占0.78%(23/2940)。作者认为对所有右半结肠大型无蒂息肉常规行内镜黏膜下剥离术不太可能改善肿瘤学结局。

要点

  • 右半结肠大型无蒂息肉中癌症总患病率为4.4%(131/2956)。
  • 右半结肠大型无蒂息肉中低风险癌占比<1%(23/2940,0.78%)。
  • 对所有右半结肠大型无蒂息肉行内镜黏膜下剥离术不太可能改善肿瘤学结局。

核心结论

  • 在大型多中心西方队列中,转诊行内镜下切除的右半结肠大型无蒂息肉含可内镜治愈的低风险癌的比例<1%。
  • 鉴于对肿瘤学结局影响甚微,对所有右半结肠大型无蒂息肉行内镜黏膜下剥离术不太可能改善患者结局。

研究设计与样本

  • 前瞻性队列研究,分析转诊行内镜下切除的大型无蒂结直肠息肉患者,纳入内镜下切除后发现癌及直接转诊外科手术者。
  • 截至2023年6月共180个月内,7个中心共2956例患者的3294枚散发型右半结肠大型无蒂息肉转诊行内镜下切除,中位大小30(四分位距22.5-37.5)mm。

主要发现

  • 63例(2.1%)患者直接转诊外科手术,其中56例(88.9%)证实为癌。
  • 2956枚息肉中2851枚(96.4%)行内镜下切除,中位大小35(四分位距25-45)mm,其中75枚(2.6%)为癌。
  • 右半结肠癌症总患病率为4.4%(131/2956)。
  • 131例癌症中115例(88%)可行详细组织病理学分析(内镜下切除后71例,直接手术44例)。
  • 排除缺失组织病理学数据后,2940枚散发型右半结肠大型无蒂息肉中23枚(0.78%)为低风险癌。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Endoscopic submucosal dissection is increasingly promoted for the treatment of all large nonpedunculated colorectal polyps (LNPCPs) to cure potential low-risk cancers (superficial submucosal invasion without additional high-risk histopathologic features). The effect of a universal en bloc strategy on oncologic outcomes for the treatment of LNPCPs in the right colon is unknown. We evaluated this in a large Western population. METHODS: A prospective cohort of patients referred for endoscopic resection (ER) of LNPCPs was analyzed. Patients found to have cancer after ER and those referred directly to surgery were included. The primary outcome was to determine the proportion of right colon LNPCPs with low-risk cancer. RESULTS: Over 180 months until June 2023, 3294 sporadic right colon LNPCPs in 2956 patients were referred for ER at 7 sites (median size 30 [interquartile range 22.5-37.5] mm). A total of 63 (2.1%) patients were referred directly to surgery, and cancer was proven in 56 (88.9%). A total of 2851 (96.4%) of 2956 LNPCPs underwent ER (median size 35 [interquartile range 25-45] mm), of which 75 (2.6%) were cancers. The overall prevalence of cancer in the right colon was 4.4% (n = 131 of 2956). Detailed histopathologic analysis was possible in 115 (88%) of 131 cancers (71 after ER, 44 direct to surgery). After excluding missing histopathologic data, 23 (0.78%) of 2940 sporadic right colon LNPCPs were low-risk cancers. CONCLUSIONS: The proportion of right colon LNPCPs referred for ER containing low-risk cancer amenable to endoscopic cure was <1%, in a large, multicenter Western cohort. A universal endoscopic submucosal dissection strategy for the management of right colon LNPCPs is unlikely to yield improved patient outcomes given the minimal impact on oncologic outcomes. CLINICALTRIALS: gov, Numbers: NCT01368289, NCT02000141.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Gauci JL, Whitfield A, Medas R, et al. Prevalence of Endoscopically Curable Low-Risk Cancer Among Large (≥20 mm) Nonpedunculated Polyps in the Right Colon. Clin Gastroenterol Hepatol. 2024. PMID: 39089517. doi:10.1016/j.cgh.2024.07.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。